Literature DB >> 20128439

Diagnosis of neurological herpesvirus infections: real time PCR in cerebral spinal fluid analysis.

Aurelia Gaeta1, Simona Verzaro, Latte Maria Cristina, Carlo Mancini, Cristina Nazzari.   

Abstract

Human herpesviruses (HHVs) cause many serious acute and persistent central nervous system (CNS) disorders. Because these infections manifest with various, often non-specific, symptoms and signs, and because specific therapy is often available, accurate diagnosis is essential. Cerebrospinal fluid (CSF) from 146 patients with acute meningitis or meningoencephalitis and 9 with "other neurological disorders" were analyzed by using an automatic system for nucleic acid extraction and quantitative real-time polymerase chain reaction (PCR) for herpes simplex 1 and 2 (HSV-1, HSV-2), Epstein-Barr virus (EBV), human cytomegalovirus (HCMV), herpesvirus-6 (HHV-6), and varicella-zoster virus (VZV). HHVs DNA was detected in 52 of 155 (33.5%) analyzed samples. In 39 CSF samples from patients with meningoencephalitis we found: VZV in 13, HSV-1 in 12, EBV in 6, HHV-6 in 4, and HSV-2 in 4. Co-infections of EBV and HSV-2, HSV-1 and HSV-2, HSV-1 and VZV were also disclosed in four cases. In addition, two patients with Guillain-Barré syndrome had HCMV and one showed HHV6 positivity, two patients with myelitis / polymyeloradiculitis had VZV and HCMV respectively, HHV-6 DNA was found in one patient with lateral amyotrophic sclerosis. Three CSF specimens from HIV-infected patients with CNS complications had HHV-6 or EBV DNA. Moreover quantitative data were also correlated to clinical conditions to obtain more information on the virus aetiopathogenic role.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20128439

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  7 in total

1.  HHV6 meningoencephalitis sequelae in previously healthy children.

Authors:  E Bozzola; A Krzysztofiak; M Bozzola; V Calcaterra; A Quondamcarlo; L Lancella; A Villani
Journal:  Infection       Date:  2012-07-18       Impact factor: 3.553

Review 2.  MENINGOENCEPHALITIS DUE TO VARICELLA ZOSTER VIRUS IN AIDS PATIENTS. REPORT OF ELEVEN CASES AND REVIEW OF THE LITERATURE.

Authors:  Marcelo Corti; María F Villafañe; Natalia Vittar; María C Banco; Maia Priarone; Lilia Mammana; Leonardo Gilardi
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

3.  Designing novel and simple competitive internal amplification control for reliable PCR diagnosis of herpes simplex virus.

Authors:  Asiye Akbarian; Mohammad Hassan Shahhosseiny; Somayeh Vafaei; Elham Moslemi; Maryam Ghahri
Journal:  Jundishapur J Microbiol       Date:  2015-02-20       Impact factor: 0.747

4.  CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; G Silling; E Schalk; W Heinz; J Panse; O Penack; M Christopeit; D Buchheidt; U Meyding-Lamadé; S Hähnel; H H Wolf; M Ruhnke; S Schwartz; G Maschmeyer
Journal:  Ann Oncol       Date:  2016-04-06       Impact factor: 32.976

5.  Coexisting infectious diseases on admission as a risk factor for mechanical ventilation in patients with Guillain-Barré syndrome.

Authors:  Shinichiro Kobori; Tatsuhiko Kubo; Makoto Otani; Keiji Muramatsu; Yoshihisa Fujino; Hiroaki Adachi; Hiromasa Horiguchi; Kiyohide Fushimi; Shinya Matsuda
Journal:  J Epidemiol       Date:  2017-03-07       Impact factor: 3.211

Review 6.  Molecular and nanotechnologic approaches to etiologic diagnosis of infectious syndromes.

Authors:  Sathish Sankar; Mageshbabu Ramamurthy; Balaji Nandagopal; Padma Srikanth; Ganesh Venkatraman; Gopalan Sridharan
Journal:  Mol Diagn Ther       Date:  2011-06-01       Impact factor: 4.074

Review 7.  Role of molecular diagnostics in the management of infectious disease emergencies.

Authors:  Neel K Krishna; Kenji M Cunnion
Journal:  Med Clin North Am       Date:  2012-09-27       Impact factor: 5.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.